PhII Study STA-9090 as Second or Third-Line Therapy for Metastatic Pancreas Cancer

Clinical trial NCT01227018 · TERMINATED

Trial details

NCT number: NCT01227018
Sponsor: Vanderbilt-Ingram Cancer Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Adenocarcinoma of the Pancreas Recurrent Pancreatic Cancer Stage IV Pancreatic Cancer

Start date: 2010-12-01
Primary completion: 2013-05-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.